Business Wire

Synchron’s Stentrode Brain-Computer Interface Receives Breakthrough Device Designation from FDA

Stentrode is the only implantable brain-computer interface that does not require open brain surgery and is currently in clinical trials SAN FRANCISCO & NEW YORK & MELBOURNE, Australia--(BUSINESS WIRE) ...
TechJuice

Brain Chip Startups Expand Trials as Global Competition Grows

Brain chip technology advances rapidly as startups expand trials, raising ethical, safety, and privacy concerns worldwide.
Business Wire

Synchron Announces Long-Term Safety Results from Fully Implanted Endovascular Brain-Computer Interface Stentrode ™ for Severe Paralysis

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...
BioWorld

Synchron raises $200M to accelerate Stentrode BCI platform

Synchron Inc.'s recent $2 million raise for its Stentrode brain-computer interface platform comes at a pivotal time for the technology. Advances in BCI development, ongoing clinical trials and growing ...
MD&M East

Apple Jumps into the Brain-Computer Interface Market with Synchron Collaboration

A new protocol will allow users implanted with Synchron’s brain-computer interface (BCI) device to control iPhone, iPad and Apple Vision Pro directly with their thoughts without the need for physical ...